Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2001
10/17/2001EP1145003A1 Method for identifying the ligands of a receptor capable of being internalized
10/17/2001EP1145002A2 Bioluminescent assay for agonists or antagonists of a calcium-coupled receptor
10/17/2001EP1145000A1 Small volume in vitro analyte sensor and related methods
10/17/2001EP1144999A1 Method and device for the cell-track-based examination and cultivation of cells
10/17/2001EP1144998A2 Neisseria genomic sequences and methods of their use
10/17/2001EP1144997A2 Methods and compounds for modulating nuclear receptor activity
10/17/2001EP1144996A2 Automatic determination of the contamination of aqueous cleaning solutions with carbonaceous compounds
10/17/2001EP1144995A1 Detection of base contaminants in gas samples
10/17/2001EP1144994A2 Method for labelling solid support bound compounds
10/17/2001EP1144980A2 A method of testing a cell sample
10/17/2001EP1144930A1 Vacuum control system for foam drying apparatus
10/17/2001EP1144692A1 Method for separating nucleic acids into populations
10/17/2001EP1144686A2 Genetic predisposition to abnormal calcification conditions
10/17/2001EP1144685A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
10/17/2001EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001EP1144681A2 Methods and kits for discovery of rna-binding compounds
10/17/2001EP1144680A2 Housing box for electronic chip with biological probes
10/17/2001EP1144679A2 Capillary array-based sample screening
10/17/2001EP1144678A2 Susceptibility to psoriasis
10/17/2001EP1144677A2 Immobilization of molecules on surfaces via polymer brushes
10/17/2001EP1144676A2 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
10/17/2001EP1144675A2 Pharmacokinetic-based drug design tool and method
10/17/2001EP1144674A1 Optimized high-throughput analytical system
10/17/2001EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
10/17/2001EP1144672A2 Tryptophan synthase as a site of herbicide action
10/17/2001EP1144671A2 Enriched central nervous system cell populations
10/17/2001EP1144669A1 Method and apparatus for the automated generation of nucleic acid ligands
10/17/2001EP1144655A2 Regulated expression using conditional er retention domains
10/17/2001EP1144650A2 Goodpasture antigen binding protein
10/17/2001EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001EP1144638A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/17/2001EP1144635A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits
10/17/2001EP1144633A1 Polypeptide
10/17/2001EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001EP1144631A2 Insulin-synthesis genes
10/17/2001EP1144627A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b
10/17/2001EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001EP1144625A2 Nucleic-acid binding proteins
10/17/2001EP1144624A2 Human and mouse trek-1 potassium channel protein and their use
10/17/2001EP1144622A2 Polynucleotides and their application in diagnostics
10/17/2001EP1144618A1 Method for isolating apoptosis-inducing dna sequences and detection system
10/17/2001EP1144617A2 Cancer-associated proteins
10/17/2001EP1144614A2 33 human secreted proteins
10/17/2001EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001EP1144586A2 Method, vessel and device for monitoring metabolic activity of cell cultures in liquid media
10/17/2001EP1144454A2 Modified peptides as therapeutic agents
10/17/2001EP1144453A1 Anti-ccr4 antibodies and methods of use therefor
10/17/2001EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function
10/17/2001EP1144449A1 Reagents and methods useful for detecting diseases of the breast
10/17/2001EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001EP1144447A2 Tuberculosis diagnostic test
10/17/2001EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001EP1144443A2 Human membrane transport proteins
10/17/2001EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001EP1144429A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/17/2001EP1144092A1 Integrated portable biological detection system
10/17/2001EP1144073A1 Magnetic separation apparatus and methods
10/17/2001EP1144050A2 Binding partners for 5-ht5-receptors for the treatment of migraine
10/17/2001EP1144007A1 Molecularly imprinted microspheres prepared using precipitation polymerisation
10/17/2001EP1144004A1 Her-2 binding antagonists
10/17/2001EP1144003A1 Methods and devices for delivery of agents to breast milk ducts
10/17/2001EP1143994A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143975A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
10/17/2001EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
10/17/2001EP1143953A2 Method of inhibiting angiogenesis
10/17/2001EP1143851A1 Method for diagnosing the presence and extent of halitosis activity
10/17/2001EP1143784A2 Soil survey device and system for precision agriculture
10/17/2001EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/17/2001EP0951704B1 Device for monitoring pollution caused by motor vehicles in an urban area
10/17/2001EP0860695A9 Method of measurement of material and testpiece
10/17/2001EP0706659B1 Device for analyzing a fluid medium
10/17/2001EP0692025B1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
10/17/2001EP0633784B2 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
10/17/2001EP0617706B1 Multivalent antigen-binding proteins
10/17/2001EP0489149B1 Probes for detecting mutant p53
10/17/2001CN1318152A Salmonella antigen formulation and kit for detecting salmonella antibodies
10/17/2001CN1318151A Analytical test device and method
10/17/2001CN1318150A Quantitative chromatographic measuring device and method for mfg. same
10/17/2001CN1318107A Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents
10/17/2001CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
10/17/2001CN1317974A Method for identifying and confirming consistent bio-functionality of natural compsns.
10/17/2001CN1317693A Magnetic particle analyzing
10/17/2001CN1317692A Biochip tester
10/17/2001CN1317691A Detector of E-type DNA chain-packet gene
10/17/2001CN1317687A Method and equipment for continuously simulating yarn load
10/17/2001CN1317575A Diagnosis based on tetrazotized zole compound
10/17/2001CN1073160C Method for sensitive detection of nuceic acids
10/17/2001CN1073118C Diagnostics virus of hepatitis C
10/17/2001CN1072963C Vaccine compsns.
10/16/2001US6303938 Method and device for detection of untextured yarn sections in textured filament yarns
10/16/2001US6303909 Waterless vessel heating system and method
10/16/2001US6303775 Polynucleotides labelled with asymmetric benzoxanthene dyes